Ardelyx, Inc. (ARDX) stock
ARDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3058% below fair value
$3.18+0.11 (+3.58%)
Close on Nov 17, 2026Market cap $792.42MP/E –Yield –
Ardelyx operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Ardelyx's operating cash flow for the twelve months ending Jun 30, 2026 was -$17.32M. For fiscal 2025 it was -$42.48M. The highest annual figure on record is $21.98M in fiscal 2012.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$42.48M | – |
| FY2024 | Dec 31, 2024 | -$44.81M | – |
| FY2023 | Dec 31, 2023 | -$89.72M | – |
| FY2022 | Dec 31, 2022 | -$70.04M | – |
| FY2021 | Dec 31, 2021 | -$152.55M | – |
| FY2020 | Dec 31, 2020 | -$81.44M | – |
| FY2019 | Dec 31, 2019 | -$76.48M | – |
| FY2018 | Dec 31, 2018 | -$70.27M | – |
| FY2017 | Dec 31, 2017 | -$65.19M | – |
| FY2016 | Dec 31, 2016 | -$92.53M | – |
| FY2015 | Dec 31, 2015 | -$71.84M | -636.2% |
| FY2014 | Dec 31, 2014 | $13.40M | +639.8% |
| FY2013 | Dec 31, 2013 | $1.81M | -91.8% |
| FY2012 | Dec 31, 2012 | $21.98M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$6.40M | – |
| Q1 FY2026 | Mar 31, 2026 | -$32.24M | – |
| Q4 FY2025 | Dec 31, 2025 | $20.95M | +113.6% |
| Q3 FY2025 | Sep 30, 2025 | $365.00K | -27.1% |
| Q2 FY2025 | Jun 30, 2025 | -$25.34M | – |
| Q1 FY2025 | Mar 31, 2025 | -$38.46M | – |
| Q4 FY2024 | Dec 31, 2024 | $9.81M | – |
| Q3 FY2024 | Sep 30, 2024 | $501.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -$19.40M | – |
| Q1 FY2024 | Mar 31, 2024 | -$35.72M | – |
| Q4 FY2023 | Dec 31, 2023 | -$8.72M | -161.0% |
| Q3 FY2023 | Sep 30, 2023 | -$21.47M | – |
| Q2 FY2023 | Jun 30, 2023 | -$14.74M | – |
| Q1 FY2023 | Mar 31, 2023 | -$44.80M | – |
| Q4 FY2022 | Dec 31, 2022 | $14.28M | – |
| Q3 FY2022 | Sep 30, 2022 | -$25.43M | – |
| Q2 FY2022 | Jun 30, 2022 | -$31.28M | – |
| Q1 FY2022 | Mar 31, 2022 | -$27.62M | – |
| Q4 FY2021 | Dec 31, 2021 | -$39.47M | – |
| Q3 FY2021 | Sep 30, 2021 | -$34.59M | – |
| Q2 FY2021 | Jun 30, 2021 | -$34.28M | – |
| Q1 FY2021 | Mar 31, 2021 | -$44.22M | – |
| Q4 FY2020 | Dec 31, 2020 | -$17.59M | – |
| Q3 FY2020 | Sep 30, 2020 | -$19.88M | – |
| Q2 FY2020 | Jun 30, 2020 | -$19.02M | – |
| Q1 FY2020 | Mar 31, 2020 | -$24.95M | – |
| Q4 FY2019 | Dec 31, 2019 | -$11.14M | – |
| Q3 FY2019 | Sep 30, 2019 | -$20.61M | – |
| Q2 FY2019 | Jun 30, 2019 | -$27.82M | – |
| Q1 FY2019 | Mar 31, 2019 | -$16.91M | – |
| Q4 FY2018 | Dec 31, 2018 | -$18.44M | -492.4% |
| Q3 FY2018 | Sep 30, 2018 | -$27.02M | – |
| Q2 FY2018 | Jun 30, 2018 | -$18.02M | – |
| Q1 FY2018 | Mar 31, 2018 | -$6.80M | – |
| Q4 FY2017 | Dec 31, 2017 | $4.70M | – |
| Q3 FY2017 | Sep 30, 2017 | -$19.24M | – |
| Q2 FY2017 | Jun 30, 2017 | -$23.89M | – |
| Q1 FY2017 | Mar 31, 2017 | -$26.76M | – |
| Q4 FY2016 | Dec 31, 2016 | -$26.75M | – |
| Q3 FY2016 | Sep 30, 2016 | -$24.64M | – |
See a number that looks wrong?